DK2952207T3 - Oliebaserede farmaceutiske sammensætninger til oral indgivelse - Google Patents

Oliebaserede farmaceutiske sammensætninger til oral indgivelse

Info

Publication number
DK2952207T3
DK2952207T3 DK15170455.8T DK15170455T DK2952207T3 DK 2952207 T3 DK2952207 T3 DK 2952207T3 DK 15170455 T DK15170455 T DK 15170455T DK 2952207 T3 DK2952207 T3 DK 2952207T3
Authority
DK
Denmark
Prior art keywords
oil
pharmaceutical compositions
oral administration
based pharmaceutical
oral
Prior art date
Application number
DK15170455.8T
Other languages
English (en)
Inventor
Nikesh Engineer
Original Assignee
Essential Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essential Pharmaceuticals Ltd filed Critical Essential Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK2952207T3 publication Critical patent/DK2952207T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK15170455.8T 2014-06-03 2015-06-03 Oliebaserede farmaceutiske sammensætninger til oral indgivelse DK2952207T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1409869.3A GB2529605B (en) 2014-06-03 2014-06-03 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK2952207T3 true DK2952207T3 (da) 2019-06-24

Family

ID=51214670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15170455.8T DK2952207T3 (da) 2014-06-03 2015-06-03 Oliebaserede farmaceutiske sammensætninger til oral indgivelse

Country Status (5)

Country Link
EP (1) EP2952207B1 (da)
AU (1) AU2015202991B2 (da)
DK (1) DK2952207T3 (da)
GB (1) GB2529605B (da)
SG (1) SG10201504332VA (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019200143A1 (en) 2018-04-11 2019-10-17 Silvergate Pharmaceuticals, Inc. Amlodipine formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US5114929A (en) * 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5795902A (en) * 1993-09-02 1998-08-18 Pfizer Inc. 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions
US5484800A (en) * 1994-08-30 1996-01-16 American Home Products Corporation Lipid-based liquid medicinal composition
EP0760237A1 (en) * 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CA2661576A1 (en) * 2006-09-26 2008-04-03 Taro Pharmaceuticals North America, Inc. Stabilizing compositions for antibiotics and methods of use
AU2010101089B4 (en) * 2010-10-06 2013-03-07 Jurox Pty Limited Parasiticidal Composition

Also Published As

Publication number Publication date
GB2529605B (en) 2018-03-21
GB2529605A (en) 2016-03-02
EP2952207B1 (en) 2019-03-27
AU2015202991A1 (en) 2015-12-17
SG10201504332VA (en) 2016-01-28
GB201409869D0 (en) 2014-07-16
EP2952207A1 (en) 2015-12-09
AU2015202991B2 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
DK3236943T3 (da) Sammensætninger til ileo-jejunal lægemiddeladministration
DK3529248T3 (da) Farmaceutiske sammensætninger
DK3089741T3 (da) Farmaceutiske sammensætninger omfattende azd9291
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
BR112016023628A2 (pt) composições farmacêuticas.
GB201419257D0 (en) Pharmaceutical compositions
BR112016026879A2 (pt) Composição farmacêutica líquida
MA50541A (fr) Formulations pharmaceutiques
DK3634468T3 (da) Fast sammensætning til oral indgivelse
MA42303A (fr) Formulations pharmaceutiques
BR112017008125A2 (pt) redução da viscosidade de formulações farmacêuticas
IL249553A0 (en) Pharmaceutical preparations
DK3821905T3 (da) Insulin indeholdende farmaceutiske sammensætninger
DK3199161T3 (da) Farmaceutisk præparat
ZA201703562B (en) Pharmaceutical composition for oral administration comprising taxane
GB201608323D0 (en) Pharmaceutical compositions
FR3027521B1 (fr) Compositions pour administration par voie orale
DK3199175T3 (da) Farmaceutisk sammensætning til injektion
HK1248544A1 (zh) 穩定的口服給藥用藥物組合物
DK3191085T3 (da) Misbrugsresistente farmaceutiske sammensætninger
PL3157506T3 (pl) Kompozycja farmaceutyczna do podawania doustnego o maskowanym smaku
DK3280447T3 (da) Farmaceutiske formuleringer
HK1245646A1 (zh) 口服給藥用醫藥組合物
IL250817A0 (en) pharmaceutical preparations
DK3256138T3 (da) Farmaceutiske sammensætninger omfattende meloxicam